載入...
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
BACKGROUND: Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancers and usually requires the administration of adjuvant chemotherapy after surgery but even with this treatment many patients still suffer from a relapse. The main objective of this study was to identify proteomic...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464546/ https://ncbi.nlm.nih.gov/pubmed/28594844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0178296 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|